全文获取类型
收费全文 | 3577篇 |
免费 | 154篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 70篇 |
妇产科学 | 39篇 |
基础医学 | 422篇 |
口腔科学 | 73篇 |
临床医学 | 218篇 |
内科学 | 1094篇 |
皮肤病学 | 32篇 |
神经病学 | 341篇 |
特种医学 | 131篇 |
外科学 | 607篇 |
综合类 | 10篇 |
预防医学 | 106篇 |
眼科学 | 26篇 |
药学 | 215篇 |
中国医学 | 4篇 |
肿瘤学 | 313篇 |
出版年
2023年 | 22篇 |
2022年 | 38篇 |
2021年 | 85篇 |
2020年 | 40篇 |
2019年 | 59篇 |
2018年 | 66篇 |
2017年 | 59篇 |
2016年 | 61篇 |
2015年 | 67篇 |
2014年 | 88篇 |
2013年 | 108篇 |
2012年 | 171篇 |
2011年 | 224篇 |
2010年 | 127篇 |
2009年 | 86篇 |
2008年 | 151篇 |
2007年 | 185篇 |
2006年 | 203篇 |
2005年 | 169篇 |
2004年 | 205篇 |
2003年 | 166篇 |
2002年 | 188篇 |
2001年 | 84篇 |
2000年 | 99篇 |
1999年 | 99篇 |
1998年 | 57篇 |
1997年 | 35篇 |
1996年 | 38篇 |
1995年 | 25篇 |
1994年 | 37篇 |
1993年 | 40篇 |
1992年 | 63篇 |
1991年 | 69篇 |
1990年 | 67篇 |
1989年 | 52篇 |
1988年 | 40篇 |
1987年 | 51篇 |
1986年 | 31篇 |
1985年 | 35篇 |
1984年 | 33篇 |
1983年 | 24篇 |
1982年 | 17篇 |
1981年 | 15篇 |
1980年 | 16篇 |
1979年 | 24篇 |
1978年 | 12篇 |
1977年 | 12篇 |
1975年 | 12篇 |
1974年 | 11篇 |
1973年 | 13篇 |
排序方式: 共有3750条查询结果,搜索用时 15 毫秒
91.
Noriko Azuma Tsukasa Okano Masanori Tamaoki Nobuyoshi Nakajima Noriko Takamura Yasushi Yokohata Junji Shindo Manabu Onuma 《Conservation Genetics Resources》2013,5(4):1001-1003
The large Japanese wood mouse (Apodemus speciosus) is common, but endemic to Japan, and its population structure was affected by habitat fragmentation because of urbanization. It suggested that the species might be one of the important models for the conservation of ecosystems and biodiversity affected by humans, including the effect of radioactive discharge caused by nuclear power plant accidents at Fukushima. We developed and characterized 25 novel polymorphic microsatellite markers from the next-generation sequencing data in an effort to provide an effective tool for genetic studies on this species. In 8 individuals from Aomori, Japan, the number of alleles and expected heterozygosities ranged from 5 to 13 and from 0.795 to 0.991, respectively, suggesting the availability of these markers for genetic studies in this species. 相似文献
92.
Kana Saito-Iizumi Akio Nakamura Tomona Matsumoto Ayano Fujiki Naoto Yamamoto Tsukasa Saito Takashi Nammoku Kensaku Mori 《Chemosensory perception》2013,6(2):92-100
The perceived intensity of the taste of a food is enhanced only if the odor of the food is perceptually similar to the taste. For example, a caramel-like odor enhances the perceived intensity of sweetness. The way gustatory and olfactory signals are integrated in the brain depends largely on one’s previous experiences with taste and odor pairings. To elucidate the effects of a sweet, sugary odor, ethylmaltol, on sucrose taste, as perceived by the central integration of flavor, we recorded salivary hemodynamic responses to the odor and taste pairings using near-infrared spectroscopy (NIRS) of seven panelists. First, we observed concentration-dependent increases in the amplitude of the responses to 0 to 6 % sucrose solutions. Second, when ethylmaltol odor was added to a 4 % sucrose solution, we observed a significant increase in the amplitude of the responses from all panelists. The addition of ethylmaltol to a tasteless solution caused no significant change in the amplitude of the salivary hemodynamic response. These results indicate that the sweet odor of ethylmaltol enhances the salivary hemodynamic response when combined with a sweet taste. Therefore, a congruent combination of sweet odor and taste greatly enhances salivary responses, which are dependent on the central integration of odor and taste. 相似文献
93.
94.
95.
Tomoki Ueda Rioko Iino Kenji Yokoyama Shinichiro Okamoto Keiko Asakura Yuiko Tsukada Jo Ishizawa Eri Matsuki Yasuo Ikeda Yutaka Hattori 《International journal of hematology》2012,96(4):477-484
In order to test for improved survival following autologous transplantation (ASCT), we conducted a prospective clinical trial of post-ASCT thalidomide therapy in Japanese patients with multiple myeloma (MM). Twenty-five newly diagnosed patients received double or single ASCT with high-dose melphalan (200?mg/m2). Two months after stem cell infusion, if the patients failed to achieve a near-complete response, thalidomide was administered at 200?mg/day until disease progression or occurrence of intolerable adverse events. Seventeen patients were in partial response or minimal response after ASCT and received thalidomide alone. Their median progression-free survival (PFS) from ASCT was 17.4?months, and the median overall survival (OS) was 42.9?months. Some patients with normal karyotype experienced durable disease stabilization for over 5?years. Five patients who exhibited high-risk chromosomal changes such as t(4;14) or deletion of chromosome 13 or 17 showed very short PFS and OS compared with those who did not. Observed grade 3 or 4 toxicities included infection in three patients, hematological toxicities in three, and gastrointestinal toxicities in two, but there was no grade 3 or higher peripheral neuropathy, probably due to appropriate dose modifications. This long-term prospective study is the first to demonstrate the feasibility of post-ASCT thalidomide therapy in Japanese patients with MM. 相似文献
96.
BackgroundHypersensitivity pneumonitis (HP) is an immune-mediated lung disease induced by inhalation of numerous antigens. Pathologically, chronic HP tends to show usual interstitial pneumonia (UIP) and fibrotic nonspecific interstitial pneumonia (fNSIP) patterns. Patients with UIP pattern present insidious onset and a risk for acute exacerbations.MethodsTo evaluate the proteomic differences of bronchoalveolar lavage fluid (BALF) between UIP and fNSIP patterns, BALF from seven patients with UIP pattern and four patients with fNSIP pattern was examined using two-dimensional gel electrophoresis and mass spectrometry.ResultsBy individually comparing each BALF sample, we found that the protein levels of surfactant protein A (SP-A), immunoglobulin heavy chain α, α-2 heat shock glycoprotein, haptoglobin β, and immunoglobulin J chain were significantly higher in the patients with UIP pattern than those in the patients with fNSIP pattern. In contrast, the protein levels of glutathione s-transferase, vitamin D-binding protein, and β-actin were significantly higher in the patients with fNSIP pattern than those in the patients with UIP pattern. To confirm the results of SP-A in the BALF proteome, we performed enzyme-linked immunosorbent assay in a larger group. The concentrations of SP-A in BALF from the patients with UIP pattern were significantly higher than those from the patients with fNSIP pattern (2.331 ± 1.656 μg/ml vs. 1.319 ± 1.916 μg/ml, p = 0.034).ConclusionsWe identified several proteins that may play roles in the development of pathological differences between UIP and fNSIP patterns of chronic HP. 相似文献
97.
Masayoshi Harigai Tsutomu Takeuchi Yoshiya Tanaka Tsukasa Matsubara Hisashi Yamanaka Nobuyuki Miyasaka 《Modern rheumatology / the Japan Rheumatism Association》2012,22(6):814-822
Objective
We implemented a retrospective study to explore discontinuation of therapy with adalimumab (ADA) without exacerbation in rheumatoid arthritis (RA) patients who had achieved low disease activity (LDA) with the biological agent.Methods
We enrolled 46 RA patients who had completed open extension of a double-blind, placebo-controlled trial of ADA monotherapy in Japan and who had LDA (DAS28-CRP <2.7) at the last administration of ADA in the extension trials; this date was defined as week 0 in the present study. Treatment of RA was at the discretion of the attending physician after week 0. The primary endpoint of this study was the percentage of patients who maintained discontinuation of biological agents and LDA for 52?weeks.Results
Twenty-four of the enrolled patients continued ADA while the rest discontinued ADA after the administration of the drug at week 0. Fourteen of the 22 patients did not restart biological agents, and 4 (18.2%) of these maintained LDA through week 52. All 4 of these patients had received ADA monotherapy before week 0.Conclusion
Some RA patients who have achieved LDA with ADA monotherapy can discontinue the biologic without incurring increased disease activity. A prospective randomized study is required to confirm the results of our study. 相似文献98.
The effect of the addition of alcohol to a Na3PO4-based electrolyte on plasma electrolytic oxidation (PEO) of AZ31B magnesium alloy was investigated. Anodization with spark discharge was conducted in Na3PO4-based electrolyte containing various alcohols (e.g., ethanol, ethylene glycol, and glycerol) at a constant current density of 200 A m−2 and a constant temperature of 25 °C. Voltage–time curves during the PEO process, the film structure, surface roughness, crystallographic structure, composition, corrosion resistance, and withstand voltage were investigated using various analytical equipment and electrochemical measurements. When the electrolyte containing alcohol was used, the initial bending voltage was higher than that observed using the basic electrolyte without alcohol addition, as was the oscillation voltage during the PEO process. For a given amount of electricity supplied, the addition of alcohol into the basic electrolyte tended to increase the thickness and corrosion resistance of PEO films formed while effectively reducing surface roughness. In particular, the addition of a polyhydric alcohol (i.e., ethylene glycol and glycerol) could act not only as a leveler for the formation of compact film but also as an enhancer for film qualities, such as corrosion resistance and withstand voltage. The patterns observed for Na3PO4-based electrolyte containing alcohol also hold for Na2SiO3-based electrolyte containing alcohol.Alcohol used as an additive could act not only as a leveler for the formation of compact film but also as an enhancer for film qualities, such as corrosion resistance and withstand voltage. 相似文献
99.
Kenji Matsuda Tsukasa Hotta Katsunari Takifuji Shozo Yokoyama Yoshimasa Oku Tadamichi Hashimoto Hiromitsu Iwamoto Hiroki Yamaue 《Surgery today》2013,43(9):984-989
Purposes
The purpose of this study was to show the clinical features of up-front surgery of the primary tumor in asymptomatic patients with incurable colorectal PC.Methods
Forty-six patients that were diagnosed between 1998 and 2007 with asymptomatic colorectal PC who could not be successfully cured by surgery were assessed retrospectively.Results
A univariate analysis revealed the presence of liver metastases, without the use of oxaliplatin (OX)/irinotecan (IRI) and without a primary tumor resection to be poor prognostic factors for survival (p = 0.044, p = 0.030, p < 0.001, respectively). According to a multivariate analysis, no use of OX/IRI and no primary tumor resection, were found to be independent poor prognostic factors for survival (HR 2.57; p = 0.047, HR 6.62; p = 0.003, respectively). The median survival time of patients treated with and without OX/IRI was 18 and 7 months, respectively. The median survival time of patients with and without primary tumor resection was 10 and 2 months, respectively. The number of patients needing surgical intervention for intestinal obstruction after surgery significantly increased in patients treated with OX/IRI (p = 0.001).Conclusion
Improvement of survival may be related to widespread use of modern systemic chemotherapy and primary tumor resection. However, an increased number of patients that needed surgery for an intestinal obstruction were observed, even after up-front surgery, when patients were treated with modern systemic chemotherapy. 相似文献100.
Hiroki Fujita Jun Koshimura Takehiro Sato Takeshi Miura Hiroshi Sasaki Tsukasa Morii 《Renal failure》2013,35(7):791-796
To explore the renoprotective and anti-inflammatory effects of pravastatin, we analyzed the changes in renal function and urinary monocyte chemoattractant protein-1 (MCP-1) level as a renal tubulointerstitial inflammatory biomarker and serum MCP-1 level as a systemic inflammatory biomarker following the introduction of treatment with 10 mg/day of pravastatin in 10 hyperlipidemic type 2 diabetic patients with normoalbuminuria. Twelve months of the pravastatin treatment did not affect urinary levels of albumin, transferrin, N-acetylglucosaminidase, or MCP-1 in the hyperlipidemic diabetic patients, whereas the treatment significantly reduced serum levels of MCP-1 in the patients. The pravastatin treatment effectively lowered low-density lipoprotein cholesterol (LDL-C) levels in the hyperlipidemic diabetic patients to levels nearly to those in 11 non-hyperlipidemic type 2 diabetic patients with normoalbuminuria. Interestingly, serum MCP-1 levels were significantly lower in the hyperlipidemic patients treated with pravastatin than in the non-hyperlipidemic patients. No significant correlation was observed between serum LDL-C and MCP-1 levels in all the data in the hyperlipidemic patients before and after the pravastatin treatment and in the non-hyperlipidemic patients. These results collectively indicate that pravastatin may ameliorate systemic vascular inflammation rather than local renal inflammation in hyperlipidemic type 2 diabetic patients with normoalbuminuria, independent of its cholesterol-lowering effects. 相似文献